BAY63-2521:Long-term Extension Study in Patients With Pulmonary Arterial Hypertension

Completed · Phase 3

Conditions studied: Hypertension, Pulmonary

In brief

Patients who have completed the 12 weeks treatment of the PATENT-1 trial (study number 12934) will be asked to participate in this long term extension study with BAY63-2521.

Key facts

Study ID
NCT00863681
Run by
Bayer
People needed
396
Starts
2009-03-12
Expected to finish
2019-08-19
Last updated by the study team
2023-11-07

Who can join

Age: 18 and older, up to 80. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

You may not qualify if…

Where it is running

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.